TABLE 1.
p53 variants | ASPP variants | Kd (NMR) | Kd (ITC) | Kd (fluorescence) |
---|---|---|---|---|
μm | μm | μm | ||
p53-PCD | ASPP2-CT | 1.3 ± 0.2a | 1.5 ± 0.1a | |
p53-PCD | iASPP-CT | 76.7 ± 10.0a | —b | |
p53-PCD2F | ASPP2-CT | 2.2 ± 0.6c | 2.3 ± 0.3a | 2.8 ± 0.6a |
p53-PCD2F | iASPP-CT | 107.5 ± 12.1c | —b | —b |
p53-PCD2F-L | ASPP2-CT | 2.2 ± 0.9c | 3.0 ± 0.5c | |
p53-PCD2F-L | iASPP-CT | 11.1 ± 1.7c | 7.7 ± 5.9c | |
p53-PCD2F-L-OD (t) | ASPP2-CT | 2.7 ± 0.6c | ||
p53-PCD2F-L-OD (t) | iASPP-CT | 7.6 ± 1.9c | ||
p53-PCD2F-L-OD-BD (t) | ASPP2-CT | 1.7 ± 0.2, 33 ± 8c,d | 1.9 ± 0.3c | |
p53-PCD2F-L-OD-BD (t) | iASPP-CT | —e | 4.6 ± 1.2c | |
p53-PCD2F-L-OD(L344R)-BD (d) | ASPP2-CT | 1.9 ± 0.2, 29 ± 7c,d | 1.7 ± 0.3c | |
p53-PCD2F-L-OD(L344R)-BD (d) | iASPP-CT | —e | 3.3 ± 1.5c | |
p53-PCD2F-L-OD(L344P)-BD (m) | ASPP2-CT | 1.5 ± 0.7c | 1.4 ± 0.3, 18 ± 5c,d | 1.6 ± 0.2c |
p53-PCD2F-L-OD(L344P)-BD (m) | iASPP-CT | 4.3 ± 1.1c | —e | 3.0 ± 0.6c |
p53-L | ASPP2-CT | 39.7 ± 4.8c | ||
p53-L | iASPP-CT | 15.9 ± 2.0c | ||
p53-L-OD-BD (t) | ASPP2-CT | 38.9 ± 5.0c | ||
p53-L-OD-BD (t) | iASPP-CT | 17.8 ± 0.9c |
Kd values were obtained in the presence of 50 mm NaCl.
ITC and fluorescence experiments were not performed for these pairs due to weak interaction.
Kd values were obtained in the presence of 150 mm NaCl.
The titration curve was best fitted to two sequential binding events.
ITC data using iASPP-CT were not analyzed, because the sample precipitated during the experiment.